MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis. - Wikidata - wikimedia - TriplyDB

MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis.

MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis.

http://www.wikidata.org/entity/Q37123430

about

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.Update on the management of ulcerative colitis.Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.

P2860

Q37423752-061494B5-1BAE-41B4-B32A-0F3293F4C963 Q37905652-F1D25F3D-A04E-4381-AEED-358F1A4C613D Q39422707-A258A0B9-F326-44A9-9D76-45E38D22384D

P2860

MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis.

http://www.wikidata.org/entity/Q37123430

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@en

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@nl

type

label

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@en

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@nl

prefLabel

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@en

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@nl

P1433

Q37123430-71EFCD50-3542-494C-B6CE-A6178C5943E6

P1476

Q37123430-672C3B7B-32B7-422A-982B-D7E79E113692

P2093

Q37123430-4E6F0A4A-5363-4E4A-84EE-F68F382CA8D0

Q37123430-DF168AA5-3BAE-4001-A943-57BD3CA158D8

P2860

Q37123430-10AC604A-1CDC-4FB1-873A-3B17567B20DC

Q37123430-19616EC9-1D7C-4B5A-9603-EFE6A0F14CEB

Q37123430-250004DC-CFC1-40A4-8401-D31C1F8D24C6

Q37123430-325CB1ED-5171-4BFD-82E9-8D4BAC107124

Q37123430-3DCD48FA-9AC4-4211-A33C-443EF2A41AC5

Q37123430-59333FCC-5E05-4CAD-B1A8-FAC50BF7EFBB

Q37123430-608E8E99-4F9D-41FC-A871-BF265A248E10

Q37123430-67624F93-1112-4793-8FF6-E64A985052D8

Q37123430-717EEECE-B247-4599-9B44-69D8B327B3CF

Q37123430-76274C8F-100E-4E72-9697-40CF5B6BD47F

P304

Q37123430-1412D2C1-9EA2-42D5-A9C2-CBBE581AF678

P31

Q37123430-E53EED7B-FB35-401E-8E25-1857BD6B9135

P356

Q37123430-B2E3D0AB-7BA9-4517-A121-48B9F7B80FB7

P407

Q37123430-04230EFF-11EB-4469-8C7A-F2C5AC4D3409

P433

Q37123430-2AF33864-B4F6-449D-AC90-64AA5B2CACC9

P478

Q37123430-794549B4-CEBD-4EB9-BE41-2E83DF936669

P577

Q37123430-5E675325-D11B-46B6-AC5A-353EA6F007CD

P698

Q37123430-5ACBF434-F1ED-4A24-806D-4A616E0D0CB8

P356

14656566.9.6.1049

P1433

Expert Opinion on Pharmacotherapy

P1476

MMX mesalamine: a novel high-d ...... eatment of ulcerative colitis.

@en

P2093

Mark A Peppercorn

http://www.w3.org/2001/XMLSchema#string

Mary Y Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

Ulcerative colitis.

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.

Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.

Systematic review: adherence issues in the treatment of ulcerative colitis.

P304

1049-1058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.9.6.1049

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18377346

http://www.w3.org/2001/XMLSchema#string